ID
25312
Description
Study part: Significant Medical/ Surgical History And Physical Examination Screening. A Single Blind, Parallel Group, Up-titration, Phase 1 Study in Healthy Volunteers to Determine a Starting Dose and Select an Up-titration Regimen for a new Formulation of Ropinirole. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Phase: phase 1. Study Recruitment Status: Completed Generic Name: ropinirole. Trade Name: Modutab, ZIPEREVE, ZEPREVE, REPREVE, ADARTREL, REQUIP, Zygara; Zygara, ZIPEREVE, ZEPREVE, Requip Depot, REQUIP, REPREVE, Modutab, ADARTREL. Study Indication : Restless Legs Syndrome. Study ID: 101468/201. Clinical Study ID: 101468/201
Keywords
Versions (4)
- 9/1/17 9/1/17 -
- 6/18/19 6/18/19 -
- 6/18/19 6/18/19 -
- 9/17/21 9/17/21 -
Copyright Holder
GlaxoSmithKline
Uploaded on
September 1, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Significant Medical/ Surgical History And Physical Examination Screening Ropinirole Restless Legs Syndrome 101468/201
Significant Medical/ Surgical History And Physical Examination Screening
Similar models
Significant Medical/ Surgical History And Physical Examination Screening
C0031809 (UMLS CUI-2)
C0543467 (UMLS CUI [2])
C0011900 (UMLS CUI [1,2])
No comments